Sansure Biotech Inc.’s Net Profit Dropped 91.9% in First Half of 2023

Sansure Biotech Inc. (圣湘生物科技股份有限公司) (688289.SH) reported a net profit of 90.9 million yuan in the first half of 2023, down 91.9% year-on-year.

Meanwhile, the company posted 427.7 million yuan in revenue, down 84.1% year-on-year.

At the end of the reporting period, it had 8.2 billion yuan in total assets and 1 billion yuan in total liabilities, with a liability-to-asset ratio of 12.1%.